8:30-10:45 PLENARY SESSION III (HALL A)
Chairs: B. Dawson-Hughes, G. Riera-Espinoza

• Plenary Lecture 5 - Region Specific Fracture Risk and Response to Therapy - E. Seeman (AU)
• IOF Medal of Achievement 
• Plenary Lecture 6 - Genetics of Osteoporosis: What Have we Learnt from Genome-wide Association Studies? - T. Spector (UK)
• IOF Pierre Delmas Award
• Oral Communications (5)

10:45-11:05
Break

11:05-12:05
Meet-the-Expert Sessions

• Side Effects of Anti Fracture Drugs - S. Adami (IT)
• Post-fracture Management - K. Akesson (SE)
• Pharmacogenomics - M.L. Brandi (IT)
• Epidemiological Aspects of Osteoporosis - C. Cooper (UK)
  
• Issues in Designing and Conducting Clinical Trials - S. R. Cummings (US)
• Genetics and Osteoporosis: How to Assess it? - S. Ferrari (CH)
• Premenopausal Osteoporosis - U. Liberman (IL)
• Bisphosphonates in Chronic Renal Failure - S.E. Papapoulos (NL)
• Osteoporosis in Men - E. Seeman (AU)
  

11:05-12:05
ESCEO-FROMO Session: Management of Osteoporosis in the Very Elderly (ROOM 11)
Chairs: J. Goldhahn, R. Rizzoli

• Welcome - J.Y. Reginster (BE)
• Specificity of the Management of Elderly Subjects - S. Boonen (BE)
• Outcomes of the ESCEO Working Group - R. Rizzoli (CH)
• Discussion - All Faculty (Moderator - J. Goldhahn)
• Adjournment - R. Rizzoli (CH)

12:05-12:15
Break

12:15-13:45
Lunch Satellite Symposium - AMGEN in collaboration with GSK
Challenges and Advances in the Treatment of Osteoporosis (HALL B)

12:15-13:45
Lunch Satellite Symposium - ROTTAPHARM / MADAUS
The Long Road Towards Disease Modification in Osteoarthritis: Current Perspectives (HALL A)

13:45-14:30
Poster Session 2

14:30-15:30
Meet-the-Expert Sessions

• Practical Approach of Glucocorticoid-treated Patients - J. Adachi (CA)
• Bone Disease in Primary Hyperparathyroidism - J.P. Bilezikian (US)
• Vertebro/kyphoplasty - S. Boonen (BE)
• Optimal Dose of Vitamin D - B. Dawson-Hughes (US)
• Muscle and Bone Interaction - D. Felsenberg (DE)
• Assessing Bone Strength Beyond DXA - C. C. Glüer (DE)
• Fracture Healing: Can we Influence it? - J. Goldhahn (CH)
• Gaits and Falls - T. Masud (UK)
  
• Health Economics and Treatment Selection - J.Y. Reginster & O. Bruyère (BE)

14:30-15:30
ESCEO-FROMO Session: Subtrochanteric Fractures After Long-Term Use of Bisphosphonates (ROOM 11)
Chairs:  C. Cooper, R. Rizzoli

• Welcome - J.Y.Reginster (BE)
• Definition and epidemiology of subtrochanteric fractures after long-term treatment with bisphosphonates - K. Åkesson (SE)
• Risks of subtrochanteric fractures after long-term bisphosphonates use -
  S.E. Papapolous (NL)
• Discussion- M.L. Bouxsein (US), Moderator
• Conclusion - R. Rizzoli (CH)
• Closing remarks

15:30-15:45
Break

15:45-17:45  PLENARY SESSION IV (HALL A)
Chairs: H. K. Genant, J.D. Adachi

• Plenary Lecture 7- Interaction Between Bone and Joints in Physiology and Disease - G. Schett (DE)
• Plenary Lecture 8 - Glitazone and Bone: A Paradigm to Better Understand Bone Physiology - C. J. Rosen (US)
  
• Oral Communications (5)

17:45-18:15
Break

18:15-19:45
Satellite Symposium - IBSA-GENEVRIER
How, When and Why: Different Approaches For a Common Disease (HALL A)

18:15-19:45
Satellite Symposium - SANOFI-AVENTIS / WARNER CHILCOTT
Osteoporosis Management: What Have We Learned From the Past Decade?(HALL B)

© Piette Communication 2008 | Web development by www.zephir.ch